Dr. Eric D. Batts, MD

Dr. Batts practices at Corewell Health Grand Rapids Hospitals - Butterworth in Grand Rapids, Michigan, part of Corewell Health.

Dr. Batts' NPI, 1821126830, was assigned on March 1, 2007. Dr. Batts graduated from University Of Michigan Medical School in 2001. Dr. Batts holds Michigan license 4301077741.

Dr. Batts' primary practice is Corewell Health Grand Rapids Hospitals - Butterworth, at 100 Michigan St NE, Grand Rapids, MI 49503 in Kent County. The practice phone is (616) 391-1774.

Dr. Batts' primary practice is Corewell Health Grand Rapids Hospitals - Butterworth in Grand Rapids, Michigan, part of Corewell Health. Dr. Batts is also affiliated with Trinity Health Grand Rapids Hospital. The medical group on file is Center for Physical Rehabilitation (CPR). Dmand AI also links Dr. Batts to 3 more hospitals and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Batts practices, 5 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Batts' primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Batts is board certified in hematology by the American Board of Internal Medicine. Dmand AI has Dr. Batts' licenses on file in 2 states: Michigan and Ohio.

Dmand AI lists breast cancer, chronic anemia, chronic leukemia, colorectal cancer, immune deficiency disease, lung cancer, lymphoma and multiple myeloma among the conditions Dr. Batts treats.

CMS data shows 13,687 Medicare services from Dr. Batts across 58 procedure codes in 2024, for 436 Medicare patients. Medicare paid $281,915 for them.

CMS counts 436 Medicare patients who saw Dr. Batts in 2024. The largest group is 65 to 74, with 195 patients. 63% of them have high cholesterol, and 62% have cancer. 9% are also on Medicaid. Their average risk score is 2.00, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Batts' median patient age at 72, with 44% women.

In 2024, Dr. Batts wrote 5,135 Medicare Part D claims for 655 patients. 77% of them were for generic drugs. CMS names the drug for 4,774 of them, across 73 drugs with 11 or more claims each, at $14,465,880 in total drug cost. In 2023, CMS named 3,847 claims across 65 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Batts for performance year 2024, reported as part of a group. Dr. Batts accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 3 papers to Dr. Batts in 2007. 2007 was the busiest year, with 2. The most frequent topics are Antineoplastic Combined Chemotherapy Protocols and Multiple Myeloma.

Dmand AI links Dr. Batts to 1 clinical trial. 1 is still active or recruiting. Conditions studied include Carcinoma, Transitional Cell and Urinary Bladder Neoplasms.

CMS Open Payments shows 436 general payments to Dr. Batts from 62 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 79% of the total. AstraZeneca Pharmaceuticals LP paid the most, $2,254.

Dmand AI lists 1 award for Dr. Batts, most recently CMS Stage 1 EHR in 2013.

Dr. Batts graduated from University Of Michigan Medical School in 2001. Dr. Batts is a member of ACP, ASCO and ASH.

Dr. Batts is in network with 20 carriers, including Aetna, Health Alliance Plan and Priority Health. HMO plans come from the most carriers, 12. Check the plan with the practice before a visit.